Log in | Register

Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 33, Issue 4

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Investigational Drugs, Volume 33, Issue 4 (2024)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Expert Opinion on Investigational Drugs, Volume 33, Issue 4 (2024)

See all volumes and issues

Volume 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Perspective

Comment

Lessons learned from early-stage clinical trials for diabetic nephropathy

Marc Rendell

Pages: 287-301

Published online: 15 Mar 2024

AbstractforLessons learned from early-stage clinical trials for diabetic nephropathy | Full Text | References | PDF (422.1 KB) | EPUB

69 Views
0 CrossRef citations
0Altmetric

Review

Review Article

Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes

Ernesto Maddaloni, Rocco Amendolara, Angela Balena, Alessandro Latino, Rosario Luigi Sessa & Raffaella Buzzetti

Pages: 303-318

Published online: 13 Mar 2024

AbstractforImmune checkpoint modulators in early clinical development for the treatment of type 1 diabetes | Full Text | References | PDF (1.8 MB) | EPUB

132 Views
0 CrossRef citations
0Altmetric

Review Article

Investigational new drugs for the treatment of chronic renal failure: an overview of the literature

Chiara Terzo, Guido Gembillo, Valeria Cernaro, Elisa Longhitano, Vincenzo Calabrese, Chiara Casuscelli, Luigi Peritore & Domenico Santoro

Pages: 319-334

Published online: 28 Mar 2024

AbstractforInvestigational new drugs for the treatment of chronic renal failure: an overview of the literature | Full Text | References | PDF (1.5 MB) | EPUB

181 Views
0 CrossRef citations
0Altmetric

Review Article

Novel preclinical developments of the primary sclerosing cholangitis treatment landscape

Aalam Sohal & Kris V. Kowdley

Pages: 335-345

Published online: 18 Mar 2024

AbstractforNovel preclinical developments of the primary sclerosing cholangitis treatment landscape | Full Text | References | PDF (1.1 MB) | EPUB

71 Views
0 CrossRef citations
0Altmetric

Review Article

Investigational drugs for the treatment of dysmenorrhea

Amelia K. Mardon, Lucy Whitaker, Toobah Farooqi, Jane Girling, Claire Henry, Carolyn Ee, Jordan Tewhaiti-Smith & Mike Armour

Pages: 347-357

Published online: 19 Mar 2024

AbstractforInvestigational drugs for the treatment of dysmenorrhea | Full Text | References | PDF (1.1 MB) | EPUB

203 Views
0 CrossRef citations
0Altmetric

Review Article

Early investigational agents for the treatment of benign prostatic hyperplasia’

Stamatios Katsimperis, Konstantinos Kapriniotis, Ioannis Manolitsis, Themistoklis Bellos, Panagiotis Angelopoulos, Patrick Juliebø-Jones, Bhaskar Somani, Andreas Skolarikos & Lazaros Tzelves

Pages: 359-370

Published online: 04 Mar 2024

AbstractforEarly investigational agents for the treatment of benign prostatic hyperplasia’ | Full Text | References | PDF (331.9 KB) | EPUB

143 Views
0 CrossRef citations
0Altmetric

Review Article

Antibacterial agents active against Gram Negative Bacilli in phase I, II, or III clinical trials

David L. Paterson

Pages: 371-387

Published online: 06 Mar 2024

AbstractforAntibacterial agents active against Gram Negative Bacilli in phase I, II, or III clinical trials | Full Text | References | PDF (492.2 KB) | EPUB

646 Views
0 CrossRef citations
0Altmetric

Review Article

Current experimental and early investigational agents for cardiac fibrosis: where are we at?

Claudio M. Ciampi, Andrea Sultana, Paolo Ossola, Andrea Farina, Gabriele Fragasso & Roberto Spoladore

Pages: 389-404

Published online: 06 Mar 2024

AbstractforCurrent experimental and early investigational agents for cardiac fibrosis: where are we at? | Full Text | References | PDF (1.8 MB) | EPUB

114 Views
0 CrossRef citations
0Altmetric

Review Article

Investigational regenerative medicine for non-traumatic osteonecrosis of the femoral head: a survey of registered clinical trials

Yutaka Kuroda, Toshiyuki Kawai, Yaichiro Okuzu, Yugo Morita & Shuichi Matsuda

Pages: 405-414

Published online: 05 Mar 2024

AbstractforInvestigational regenerative medicine for non-traumatic osteonecrosis of the femoral head: a survey of registered clinical trials | Full Text | References | PDF (510.8 KB) | EPUB

45 Views
0 CrossRef citations
0Altmetric

Review Article

Microbiome modulators for atopic eczema: a systematic review of experimental and investigational therapeutics

Jonathan D. Greenzaid, Lina J. Chan, Brittany M. Chandani, Nicholas R. Kiritsis & Steven R. Feldman

Pages: 415-430

Published online: 06 Mar 2024

232 Views
0 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Investigational drugs for the treatment of acromegaly: new agents to transform therapy

Rosa Pirchio et al.

Review Article | Published online: 30 Apr 2024

Safety, tolerability, and pharmacokinetics of the novel RdRp inhibitor SHEN26 against SARS-CoV-2: a randomized, placebo-controlled, double-blind Phase I study in healthy subjects

Cheng Sun et al.

Article | Published online: 30 Apr 2024

Frontotemporal dementia: from genetics to therapeutic approaches

Francesca R. Buccellato et al.

Review Article | Published online: 30 Apr 2024

Open Access

Drugs in preclinical and early clinical development for the treatment of chagas disease: the current status

Fernanda Karoline Vieira da Silva Torchelsen et al.

Review Article | Published online: 30 Apr 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.33, Iss.4, 2024)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?